返回

Fortitude pays ~$1M for 9.4% of HeartSciences at 22% premium

Fortitude paid approximately $1 million for a 9.4% stake in HeartSciences at a 22% premium before shareholders vote on the proposed merger. The vote date has not been set, and failure to approve the deal could leave HeartSciences facing liquidation.

本网站上的信息是使用AI生成的，我们无法保证其准确性。 请仅作为参考信息使用。